608 related articles for article (PubMed ID: 23273978)
1. eRNAs are required for p53-dependent enhancer activity and gene transcription.
Melo CA; Drost J; Wijchers PJ; van de Werken H; de Wit E; Oude Vrielink JA; Elkon R; Melo SA; Léveillé N; Kalluri R; de Laat W; Agami R
Mol Cell; 2013 Feb; 49(3):524-35. PubMed ID: 23273978
[TBL] [Abstract][Full Text] [Related]
2. ChIP (chromatin immunoprecipitation) analysis demonstrates co-ordinated binding of two transcription factors to the promoter of the p53 tumour-suppressor gene.
Polson A; Takahashi P; Reisman D
Cell Biol Int; 2010 Sep; 34(9):883-91. PubMed ID: 20446924
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of p53 by Pitx1.
Liu DX; Lobie PE
Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
[TBL] [Abstract][Full Text] [Related]
4. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene.
Pnueli L; Rudnizky S; Yosefzon Y; Melamed P
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4369-74. PubMed ID: 25810254
[TBL] [Abstract][Full Text] [Related]
5. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
[TBL] [Abstract][Full Text] [Related]
6. A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.
Melo CA; Léveillé N; Rooijers K; Wijchers PJ; Geeven G; Tal A; Melo SA; de Laat W; Agami R
Oncogene; 2016 Aug; 35(33):4399-406. PubMed ID: 26776159
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
[TBL] [Abstract][Full Text] [Related]
8. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
Sadasivam S; Gupta S; Radha V; Batta K; Kundu TK; Swarup G
Oncogene; 2005 Jan; 24(4):627-36. PubMed ID: 15580302
[TBL] [Abstract][Full Text] [Related]
9. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
10. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
12. eRNA binding produces tailored CBP activity profiles to regulate gene expression.
Bose DA; Berger SL
RNA Biol; 2017 Dec; 14(12):1655-1659. PubMed ID: 28891741
[TBL] [Abstract][Full Text] [Related]
13. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
Millau JF; Bastien N; Bouchard EF; Drouin R
Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
[TBL] [Abstract][Full Text] [Related]
14. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
15. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
16. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
Schavolt KL; Pietenpol JA
Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
[TBL] [Abstract][Full Text] [Related]
17. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
[TBL] [Abstract][Full Text] [Related]
18. Multiple response elements and differential p53 binding control Perp expression during apoptosis.
Reczek EE; Flores ER; Tsay AS; Attardi LD; Jacks T
Mol Cancer Res; 2003 Dec; 1(14):1048-57. PubMed ID: 14707288
[TBL] [Abstract][Full Text] [Related]
19. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
20. Mitofusin-2 is a novel direct target of p53.
Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
